Egyptian International Pharmaceutical Industries Company (EGX:PHAR)

Egypt flag Egypt · Delayed Price · Currency is EGP
82.99
+0.01 (0.01%)
At close: Apr 27, 2026
69.30%
Market Cap 14.60B
Revenue (ttm) 9.44B
Net Income (ttm) 1.44B
Shares Out 168.76M
EPS (ttm) 8.89
PE Ratio 9.73
Forward PE 10.00
Dividend 1.50 (1.73%)
Ex-Dividend Date Apr 28, 2026
Volume 189,500
Average Volume 287,432
Open 86.48
Previous Close 82.98
Day's Range 86.10 - 87.30
52-Week Range 43.60 - 88.99
Beta 0.57
RSI 64.25
Earnings Date May 14, 2026

About EGX:PHAR

Egyptian International Pharmaceutical Industries Company manufactures and sells pharmaceutical ampoules in Egypt and internationally. The company offers analgesics and antipyretic; analgesics and anti-inflammatory; anti-infective; antihistamine; cardiovascular and metabolic; corticosteroids; gastrointestinal tract; nervous system; ophthalmic; respiratory; topical ointment and cream; vitamins; and miscellaneous products. It also exports its products. Egyptian International Pharmaceutical Industries Company was incorporated in 1980 and is based i... [Read more]

Industry Pharmaceutical Preparations
Founded 1980
Country Egypt
Stock Exchange Egyptian Stock Exchange
Ticker Symbol PHAR
Full Company Profile

Financial Performance

In 2025, EGX:PHAR's revenue was 9.44 billion, an increase of 24.38% compared to the previous year's 7.59 billion. Earnings were 1.44 billion, an increase of 31.57%.

Financial Statements

News

There is no news available yet.